Physician profile
Gary Elizabeth Conly
NPI 1679162085
$5,766.46
in general payments reported to CMS, 2019-2025
9 companies · $1,948 in 2025
The $1,948 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $517 · 2023: $261 · 2024: $2,795 · 2025: $1,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,553 · Food and Beverage: $2,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,552.55 |
| Food and Beverage | $2,451.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,656.78 | 2021-2025 | Cardioinsight, Linq II, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $366.46 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $339.44 | 2022-2023 | Camzyos |
| Cardiva Medical, INC. | $105.26 | 2021-2022 | |
| Esperion Therapeutics, INC. | $103.86 | 2021 | |
| Cvrx, INC. | $101.86 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.43 | 2025 | Lifevest |
| Philips North America LLC | $22.83 | 2022 | |
| Convatec INC. | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Conly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.